| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8580400 | Primary Care Diabetes | 2018 | 6 Pages |
Abstract
Compared to baseline HbA1c, patients treated by APN-IMP and IMP-ancillary provider groups had equivalent reductions in HbA1c.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Patricia A. Marin, James F. Bena, Nancy M. Albert,